On the 5th of August 2020, ContextVision held an Extraordinary General Meeting in Stockholm. The Board’s proposal for adoption of new articles of association was approved The Board’s proposal for decision on the share split of the company’s share was approved No other matters were processed at the meeting. For further information, please contact:Ann-Charlotte Linderoth […]
ContextVision just launched the company’s first CE marked digital pathology product based on artificial intelligence. In this podcast the company’s CEO Fredrik Palm and Dr. Filippo Fragetta, the chief pathologist at the Cannizzaro Hospital, will talk about the revolution we are approaching within digital pathology. Listen here
ContextVision today announced that its first digital pathology product in a planned portfolio has been granted CE mark status. This means that INIFY® Prostate Screening is now available for routine clinical use within the European Union.
ContextVision hereby invites shareholders to an Extraordinary General Meeting on August 5, 2020. Please find attached the invitation including agenda and details on how to register. Please contact: for any questions regarding the Extraordinary General Meeting.
Today ContextVision presented the company at a webinar arranged by SpareBank 1 Markets in Norway. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website.
STOCKHOLM – May 27, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announced the release of RiventTM, its seventh generation of image enhancement software for 2D ultrasound.
Fredrik Palm, CEO of ContextVision, has on May 19, 2020 purchased 120 shares in ContextVision AB at an average price of NOK 155 per share. After the transaction, Mr Palm holds a total of 2620 shares in ContextVision AB.
ContextVision today announced the strengthening of its board of directors. Martin Ingvar, Professor of Integrative Medicine at Karolinska Institute Sweden and founding member of International Consortium for Health Outcome Measurements (ICHOM), was elected as new member of the board at the annual general meeting.
On the 6th of May 2020, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The annual financial report regarding 2019 was presented and approved by the AGM. Disposition of financial results according to the proposal of the Board of Directors was approved. The Managing Director and the Board of Directors were discharged from […]
Stockholm, May 6, 2020 The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation. The ContextVision AB:s Profit Sharing Foundation has sold 30,500 shares on April 28, at an average price of 120 NOK/share, in accordance with the rules related to the […]